RxDoctor Payments Data

Kayde Moore

Physician Assistant · Brunswick, GANPI 1891184453

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $15,131 of the $17,486 with a category attached, or 86.5%. It is spread thinly across 60 manufacturers, the largest accounting for just 10.4% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,486in general payments, 2019–2025

Across 739 payments — averaging $23.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • AstraZeneca$1K
  • Pfizer$1K
  • Johnson & Johnson$1K
  • Merck$830
  • Takeda Pharmaceuticals U.S.A., Inc.$756
  • plus $11K from 54 others

What the payments were for

  • Consulting fees$140%
  • Food & beverage$15,13187%
  • Education$1,3778%
  • Other$9646%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis59$1,812
AstraZeneca(2 entities)46$1,202
Pfizer56$1,021
Johnson & Johnson34$1,016
Merck34$830
Takeda Pharmaceuticals U.S.A., Inc.21$756
Gilead(2 entities)25$657
E.r. Squibb & Sons, L.L.C.28$459
Incyte Corporation17$433
Eisai Inc.21$412
Amgen26$405
Seagen Inc.16$403
Sanofi14$398
Bristol Myers Squibb20$380
Astellas Pharma US Inc9$357
Bayer16$332
Regeneron Healthcare Solutions, Inc.15$325
GSK16$323
AbbVie12$317
Taiho Oncology, Inc.12$313
Daiichi Sankyo Inc.15$310
Genentech USA, Inc.15$305
Sobi, Inc11$297
Lilly USA, LLC13$277
Exelixis Inc.11$242
Boehringer Ingelheim9$226
Tersera Therapeutics LLC9$205
G1 Therapeutics, Inc.6$185
Pharmacosmos Therapeutics Inc.10$180
Stemline Therapeutics Inc.7$171
Puma Biotechnology, Inc.8$166
Octapharma USA, Inc.7$157
Servier Pharmaceuticals LLC8$149
Rigel Pharmaceuticals, Inc.8$147
Karyopharm Therapeutics Inc.3$146
Jazz Pharmaceuticals Inc.7$145
Mirati Therapeutics, Inc.7$137
Janssen Scientific Affairs, LLC1$137
Array Biopharma Inc10$136
Beigene USA, Inc.7$118
Pharmaessentia USA Corporation5$102
Boston Scientific1$95
Menarini Silicon Biosystems, Inc.2$83
Pharmacyclics LLC, An Abbvie Company5$81
Beone Medicines USA, Inc.4$74
Recordati_rare_diseases_inc.3$70
Deciphera Pharmaceuticals Inc.3$68
CSL Behring3$66
Novocure Inc.4$60
ADC Therapeutics America, Inc.3$56
Morphosys, US Inc.3$55
Tolmar, Inc.2$50
Springworks Therapeutics, Inc.2$47
Spectrum Pharmaceuticals Inc.2$41
Acrotech Biopharma Inc.2$40
AVEO Pharmaceuticals, Inc.2$39
ADMA Biomanufacturing LLC2$39
Ipsen Biopharmaceuticals, Inc2$37
Legend Biotech USA Inc.2$37
Syndax Pharmaceuticals, Inc.2$34

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,486 in reported general payments places this provider in the 95th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$95,809
Medicare patients
87
Services billed
3,184

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban28$16,702
Enoxaparin Sodium14$3,529
Anagrelide Hcl22$1,328
Letrozole16$938
Ibandronate Sodium19$478
Raloxifene Hcl17$382
Ondansetron OdtOndansetron20$292
Anastrozole26$260
Hydroxyurea26$227
Dexamethasone11$123
Spironolactone15$113
Levothyroxine Sodium13$106
Furosemide20$62

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$1,021$16,70228 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Brunswick

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →